Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
X-linked myotubular myopathy (XLMTM) is a severe muscle disease with no effective treatment. Here, the authors show that tamoxifen, a drug used to treat breast cancer, rescues the pathology in a mouse model of the disease, at least in part by normalizing expression of the disease modifier proteins D...
Enregistré dans:
Auteurs principaux: | Elinam Gayi, Laurence A. Neff, Xènia Massana Muñoz, Hesham M. Ismail, Marta Sierra, Thomas Mercier, Laurent A. Décosterd, Jocelyn Laporte, Belinda S. Cowling, Olivier M. Dorchies, Leonardo Scapozza |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/55e31f0f62ce4d928b4e2b13a82b1d60 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
par: Raquel Gómez-Oca, et autres
Publié: (2021) -
Tamoxifen therapy in a murine model of myotubular myopathy
par: Nika Maani, et autres
Publié: (2018) -
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
par: Hichem Tasfaout, et autres
Publié: (2017) -
Integrative data mining highlights candidate genes for monogenic myopathies.
par: Osorio Abath Neto, et autres
Publié: (2014) -
Atrial Myopathy Underlying Atrial Fibrillation
par: Harold Rivner, et autres
Publié: (2020)